首页> 外文期刊>Journal of infection and public health. >Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: A preliminary report
【24h】

Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: A preliminary report

机译:评价热休克蛋白以区分潜伏性结核感染和活动性肺结核的初步报告

获取原文
获取原文并翻译 | 示例
           

摘要

The diagnosis of a latent tuberculosis infection (LTBI) is of the utmost concern. The available tests, the tuberculin skin test (TST) and the QuantiferonTB Gold test (QFT-G) cannot discriminate between active TB and LTBI. Therefore, the aim of the study is to identify new biomarkers that can discriminate between active TB and LTBI and can also assess the risk of the individual developing active TB. In total, 55 blood samples were collected, of which 10 samples were from the active TB infection group, 10 were from the high-risk exposure group, 23 were from the low-risk exposure group, and 12 were from healthy controls living in a non-TB endemic area. A panel of heat shock proteins (Hsps), including host Hsp25, Hsp60, Hsp70, and Hsp90 and Mycobacterium tuberculosis (MTB) Hsp16, were evaluated in all of the collected samples using ELISA. The levels of the host Hsp(s) (Hsp25, Hsp60, Hsp70 and Hsp90) and MTB Hsp16 were significantly (p <0.05) elevated in the active TB group compared to the high-risk exposure group, the low-risk exposure group and the control group. Notably, the levels of the same panel of Hsp(s) were elevated in the high-risk exposure group compared to the low-risk exposure group. On follow-up, out of the 10 high-risk exposure participants, 3 converted into active TB, indicating that this group has the highest risk of developing TB. Thus, the evaluated panel of Hsp(s) can discriminate between LTBI and active TB. They can also identify individuals who are at the highest risk of developing active TB. Because they can be rapidly detected, Hsp(s) have an edge over the existing diagnostic tools for LTBI. The evaluation of these proteins will be useful in designing better diagnostic methods for LTBI. (C) 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
机译:潜伏性结核感染(LTBI)的诊断是最需要关注的。可用的测试,结核菌素皮肤测试(TST)和QuantiferonTB Gold测试(QFT-G)不能区分活动性TB和LTBI。因此,该研究的目的是确定可以区分活动性结核病和LTBI的新生物标志物,还可以评估个体发展为活动性结核病的风险。总共收集了55个血液样本,其中10个样本来自活动性结核感染组,10个样本来自高风险暴露组,23个样本来自低风险暴露组,12个样本来自健康对照组。非结核病流行地区。使用ELISA在所有收集的样品中评估了一组热休克蛋白(Hsps),包括宿主Hsp25,Hsp60,Hsp70和Hsp90和结核分枝杆菌(MTB)Hsp16。与高风险暴露组,低风险暴露组和高风险暴露组相比,活动性结核病组的宿主Hsp(一种或多种)(Hsp25,Hsp60,Hsp70和Hsp90)和MTB Hsp16的水平显着升高(p <0.05)。对照组。值得注意的是,与低风险暴露组相比,高风险暴露组的同一组Hsp水平升高。随访时,在10位高风险暴露参与者中,有3位转化为活动性结核病,表明该人群患结核病的风险最高。因此,评估的Hsp专家组可以区分LTBI和活动性TB。他们还可以确定罹患活动性结核病风险最高的个人。由于可以快速检测到它们,因此Hsp在LTBI的现有诊断工具上具有优势。这些蛋白质的评估将有助于设计更好的LTBI诊断方法。 (C)2015年沙特·本·阿卜杜勒阿齐兹国王健康科学大学。由Elsevier Limited发布。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号